Aequus Pharmaceuticals Inc (AQS.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 584 | 255 | 1,380 | 2,715 | 2,593 |
| Cost of Goods | 252 | 111 | 104 | 26 | N/A |
| Gross Profit | 332 | 144 | 1,276 | 2,689 | N/A |
| Operating Expenses | 2,460 | 2,964 | 3,774 | 4,056 | 3,119 |
| Operating Income | -2,127 | -2,820 | -2,498 | -1,367 | -526 |
| Interest Expense | 253 | 145 | 214 | 455 | 520 |
| Other Income | 203 | 1 | -498 | 13 | 0 |
| Pre-tax Income | -2,178 | -2,965 | -3,210 | -1,810 | -1,045 |
| Net Income Continuous | -2,178 | -2,965 | -3,210 | -1,810 | -1,045 |
| Net Income | $-2,178 | $-2,965 | $-3,210 | $-1,810 | $-1,045 |
| EPS Basic Total Ops | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 |
| EBITDA(a) | $-1,792 | $-2,681 | $-2,866 | $-1,227 | $-315 |